Gracell Biotechnologies Inc ADR
(GRCL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 0 | 0 | 0 | 57 | 0 |
| Gross Profit | N/A | N/A | N/A | 57 | N/A |
| Operating Expenses | 21,771 | 25,196 | 22,744 | 20,405 | 14,820 |
| Operating Income | -21,771 | -25,196 | -22,744 | -20,348 | -14,820 |
| Interest Expense | 247 | 225 | 218 | 169 | 219 |
| Other Income | 175 | 406 | 1,940 | 453 | 138 |
| Pre-tax Income | -21,843 | -25,015 | -21,022 | -20,064 | -14,901 |
| Net Income Continuous | -21,843 | -25,015 | -21,022 | -20,064 | -14,901 |
| Net Income | $-21,843 | $-25,015 | $-21,022 | $-20,064 | $-14,901 |
| EPS Basic Total Ops | -0.30 | -0.35 | -0.33 | -0.30 | -0.22 |
| EPS Basic Continuous Ops | -0.32 | -0.37 | -0.31 | -0.30 | -0.22 |
| EPS Diluted Total Ops | -0.30 | -0.35 | -0.33 | -0.30 | -0.22 |
| EPS Diluted Continuous Ops | -0.32 | -0.37 | -0.31 | -0.30 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.32 | -0.37 | -0.30 | N/A | N/A |
| EBITDA(a) | $-21,771 | $-25,196 | $-22,744 | $-20,348 | $-14,820 |